Avopef
etoposide
- Strength
- 500 mg/25mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Avyxa Pharma, LLC
etoposide
Listed by Avyxa Pharma, LLC
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Topoisomerase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 83831-144 |
| FDA application | NDA220200 |
| RxNorm concept | 310248 |
| Package sizes listed | 1 |
| Marketed since | April 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
etoposide
Avyxa Pharma, LLC
etoposide phosphate
H2-Pharma, LLC
BluePoint Laboratories
Mylan Pharmaceuticals Inc.
Accord Healthcare Inc.
Hikma Pharmaceuticals USA Inc.
Meitheal Pharmaceuticals Inc.
Hikma Pharmaceuticals USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.